GHK BPC-157 TB-500 Blend – Product Specifications and Laboratory Testing

Product Overview

The GHK BPC-157 TB-500 Blend from Global Peptides Lab is a lyophilized research peptide formulation containing three distinct peptide-related components: GHK-Cu, BPC-157 and TB-500 (TB4). The product is supplied as a powder in a 7 mL (6R) vial and is provided in a non-reconstituted state.

This product page presents the available composition information, physical specifications and batch-specific laboratory test results to help research professionals review the product’s documented characteristics. It is designed to provide clear product information without making unsupported claims about biological effects, clinical benefits or suitability for human use.

The reported purity is approximately 99%. The accompanying test information is dated April 1, 2026, and identifies batch GL04260570D. Buyers and research professionals should review the relevant laboratory documentation to confirm the scope, methods and results of each test.

GHK-Cu, BPC-157 and TB-500: Understanding the Components

GHK-Cu

GHK-Cu is a copper-binding tripeptide studied in biochemical and laboratory research. Its structure includes glycine, histidine and lysine associated with copper. GHK-Cu is also known as a copper peptide and is a commonly used term in scientific literature concerning peptide chemistry.

Within this blend, GHK-Cu is listed as a separately quantified component. The supplied batch information reports 60.62 mg of GHK-Cu. This figure represents the reported component content for the tested sample and should not automatically be interpreted as a guaranteed amount in every vial without the relevant batch documentation.

BPC-157

BPC-157 is a synthetic peptide that has been investigated in preclinical research. Its inclusion in this product refers to its presence as one of the three listed components, rather than evidence of an approved therapeutic application.

The supplied test information reports 11.07 mg of BPC-157. Researchers should consult appropriate scientific literature and regulatory information when evaluating the compound, its experimental status and the limitations of existing evidence.

TB-500 (TB4)

TB-500 is a name used for products associated with thymosin beta-4-related research. The exact identity and sequence of a material sold under this name should be verified using its technical documentation, since naming conventions alone do not establish molecular identity.

The batch information provided for this blend lists 11.22 mg of TB-500 (TB4). Researchers should check the accompanying analytical report for the specific identity and testing methods used for this component.

Product Specifications

The GHK BPC-157 TB-500 Blend is supplied as a lyophilized powder. Lyophilization is a freeze-drying process used in the preparation of certain laboratory materials. The product has not been reconstituted and is supplied in powder form.

The vial is identified as a 7 mL (6R) vial. Vial capacity is a physical container specification; it does not independently establish the exact fill mass, usable volume or concentration of the material.

The available product specifications are as follows:

• Product name: GHK BPC-157 TB-500 Blend
• Brand: Global Peptides Lab
• Form: Lyophilized powder
• Container: Vial
• Vial specification: 7 mL (6R)
• Preparation status: Not reconstituted
• Reported purity: Approximately 99%
• GHK-Cu content: 60.62 mg
• BPC-157 content: 11.07 mg
• TB-500 (TB4) content: 11.22 mg
• Batch number: GL04260570D
• Reported testing date: April 1, 2026

These specifications reflect the information supplied for the identified batch. For independent verification, consult the complete certificate of analysis and confirm that it corresponds to the product and batch being reviewed.

Laboratory Testing and Quality Information

Laboratory testing provides information about selected characteristics of a research material. However, the value of a test result depends on the analytical method, acceptance criteria, laboratory competence and documentation supporting the result.

The supplied product information identifies the following testing categories:

• Purity
• Weight
• TFA-free status
• Sterility
• Endotoxins (LPS)

The reported results specifically state approximately 99% purity, a passing sterility result and a passing endotoxin result. The supplied record does not include a separate numerical weight result or detailed analytical evidence for TFA-free status. Those details should be checked against the complete laboratory report rather than assumed from the list of testing categories.

For batch GL04260570D, the reported endotoxin result is Pass, and the reported sterility result is Pass. These findings should be understood within the scope and limitations of the tests performed. They do not establish clinical safety, therapeutic efficacy or suitability for injection or any other human use.

Packaging and Product Handling Information

The product is supplied as a non-reconstituted, lyophilized powder in a vial. Buyers should inspect the packaging and batch identification when receiving the product and compare the information against the corresponding technical documentation.

Storage conditions should be determined from validated product-specific stability information and the manufacturer’s documented requirements. Avoid assuming that a particular temperature, storage period or handling procedure is appropriate unless it is supported by the product documentation.

This page does not provide reconstitution instructions, administration guidance or dosage recommendations. Such information should not be inferred from vial size, component mass or purity figures.

Frequently Asked Questions

What is the GHK BPC-157 TB-500 Blend?

It is a lyophilized powder blend listed as containing GHK-Cu, BPC-157 and TB-500 (TB4). Its supplied product information includes component quantities and selected batch laboratory results.

What is the reported purity?

The supplied batch information reports approximately 99% purity. The complete analytical report should be consulted to identify the test method and the basis on which purity was calculated.

What are the reported component quantities?

The provided figures are 60.62 mg of GHK-Cu, 11.07 mg of BPC-157 and 11.22 mg of TB-500 (TB4). Refer to the relevant batch documentation to verify these values and understand the measurement method.

Is the product supplied as a liquid?

No. The supplied product is described as a lyophilized powder and is identified as not reconstituted.

What laboratory results are available?

The supplied information reports approximately 99% purity, a Pass result for sterility and a Pass result for endotoxins (LPS). The full report should be reviewed for test methods, acceptance criteria, weight results and evidence relating to TFA-free status.

Does a passing laboratory result prove the product is safe for human use?

No. Selected laboratory results do not establish safety or effectiveness in humans. Product identity, quality, clinical evidence and regulatory status are separate considerations.

Important Research-Use Notice

The GHK BPC-157 TB-500 Blend is presented for laboratory research purposes only. BPC-157 and TB-500 are not established, approved treatments for human disease, and the presence of GHK-Cu does not establish that the combined product has a proven clinical benefit. This listing should not be interpreted as a recommendation for self-administration or as a claim that the blend is approved for human or veterinary use.

Global Peptides Lab aims to present product specifications and available test information clearly so that qualified research professionals can assess the documented characteristics of the material. Always review the relevant batch documentation, applicable regulations and scientific evidence before making research or procurement decisions.

Product summary: A three-component lyophilized research blend, supplied in a 7 mL (6R) vial, with reported component quantities and selected batch laboratory results for batch GL04260570D, dated April 1, 2026.